Abstract:Objective To explore the effects of advanced glycation end products (AGEs) on oxidative stress in insulin-secreting-1 (INS-1) cells. Methods After being cultured with different concentrations of AGEs (AGE-1, AGE-2 and AGE-3), INS-1 cell viability was detected by methyl thiazolyl tetrazolium (MTT); 2,7-dichlorofluorescein diacetate (DCFH-DA) was used as a trapping agent of reactive oxygen species (ROS). The fluorescence intensity of 2,7-dichlorofluorescein (DCF), which was the product of cellular oxidation of DCFH-DA, was detected by flow cytometry, and the level of ROS was thus measured. Results There was no significant difference in the viability of INS-1 between the AGE-1 un-treated group and the AGE-1 treated groups (all P>0.05). INS-1 cell viability was significantly decreased in the AGE-2 and AGE-3 treated groups with the dose of 200 and 400 mg/L AGE as compared with the AGE-2 and AGE-3 un-treated groups (all P<0.05). The cell viability was negatively correlated with the dose of AGE-2 and AGE-3 (r=-0.871, -0.912, both P<0.05). The viability of INS-1 cells with 24 h,48 h,72 h AGEs treatment was significantly lower than that with 12 h treatment in the AGE-2 and AGE-3 treated groups with the dose of 200 mg/L (all P<0.05). There was no significant difference in the level of ROS in INS-1 between the AGE-1 un-treated group and the AGE-1 treated groups (all P>0.05). The levels of ROS were significantly higher in the 200 mg/L and 400 mg/L AGE-2 groups and 100 mg/L, 200 mg/L and 400 mg/L AGE-3 groups than those in the AGE-2 and AGE-3 untreated groups (all P<0.05). There was no significant difference in the level of ROS in the 200 mg/L AGE-1 group between different time points (all P>0.05). But the level of ROS in INS-1 cells with 200 mg/L AGE-2 and AGE-3 treatment for 24 h, 48 h and 72 h were significantly higher than baseline (all P<0.05). Conclusion AGE-2 and AGE-3 can induce oxidative stress and cell damage in INS-1 cells.

Effects of advanced glycation end products on oxidative stress in insulin-secreting-1 cells